Holen Sie sich die Stockscreener-App
3.33
7.07%
0.22
Handel nachbörslich:
3.35
0.02
+0.60%
Schlusskurs vom Vortag:
$3.11
Offen:
$3.16
24-Stunden-Volumen:
5.98M
Relative Volume:
1.10
Marktkapitalisierung:
$342.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-283.26M
KGV:
-2.2653
EPS:
-1.47
Netto-Cashflow:
$-273.61M
1W Leistung:
-21.65%
1M Leistung:
-20.33%
6M Leistung:
+18.51%
1J Leistung:
-32.04%
1-Tages-Spanne:
$3.11
$3.40
1-Wochen-Bereich:
$2.85
$3.40
52-Wochen-Spanne:
$1.26
$7.30
Sana Biotechnology Inc Stock (SANA) Company Profile
Firmenname
Sana Biotechnology Inc
Sektor
Branche
Telefon
(206) 701-7914
Adresse
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Vergleichen Sie SANA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
3.33 | 789.60M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-03-18 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | Eingeleitet | Jefferies | Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-11-05 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-01-16 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-05 | Eingeleitet | Citigroup | Buy |
| 2023-08-14 | Eingeleitet | TD Cowen | Market Perform |
| 2023-05-02 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-03-01 | Eingeleitet | BofA Securities | Buy |
| 2021-03-01 | Eingeleitet | Goldman | Neutral |
| 2021-03-01 | Eingeleitet | JP Morgan | Neutral |
| 2021-03-01 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Sana Biotechnology Inc Aktie (SANA) Neueste Nachrichten
Quant Funds Rotate Into Sana Biotechnology Inc. Stock2025 Market Overview & Real-Time Stock Price Movement Reports - 선데이타임즈
Sana Biotechnology shares rise 6.34% intraday after positive clinical results and FDA meeting. - AInvest
Sana Biotech Bails on Factory in Old AT&T Call Center - Yahoo Finance
Sana: Q2 Earnings Snapshot - New Haven Register
Is Sana Biotechnology Inc. stock a value trapGolden Crossover Alert - kangso.co.kr
Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates - GlobeNewswire
Sana Biotechnology SANA 2025Q2 Earnings Preview Upside Expected with New Product Pipeline Developments - AInvest
Institutional Investors May Adopt Severe Steps After Sana Biotechnology, Inc.'s (NASDAQ:SANA) Latest 29% Drop Adds to a Year Losses - 富途牛牛
Sana suspends build-out of Bothell manufacturing facility - The Business Journals
SANASana Biotechnology, Inc. Latest Stock News & Market Updates - Stock Titan
Sana Biotechnology: A High-Risk, High-Reward Play on a Potential Diabetes Cure - AInvest
Sana Biotechnology drops 13% on $75M stock issuance, prices at $3.35 - MSN
Sana Biotechnology options signal 10.8% potential stock price movement after earnings - AInvest
Sana Biotechnology (SANA) Rated ‘Market Perform’ on Diabetes Program Prospects - MSN
Sana Biotechnology Announces Public Offering Pricing - The Globe and Mail
Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued (NASDAQ:SANA) - Seeking Alpha
Sana Biotechnology shares rise 3.03% premarket after pricing $75 million share offering. - AInvest
Sana Biotechnology Announces Pricing of Public Offering - GlobeNewswire
Seattle biotech firm Sana Biotechnology raising $75 million through public offering - The Business Journals
Sana Biotechnology Announces $69.9mln Public Offering of 20.9mln Shares - AInvest
ALRM shifts unused 2015 shares to 2025 equity plan; no new dilution | SANA SEC FilingForm 8-K - Stock Titan
Sana Biotechnology (SANA.O) Plummets 28% – What’s Behind the Sudden Drop? - AInvest
Sana Biotechnology Plummets 30.5% Intraday: A Technical and Order-Flow Deep Dive - AInvest
Sana Biotechnology Plummets 30%: A Bearish Storm Unfolds as Capital Raise Sparks Investor Exodus - AInvest
Sana Biotechnology stock tumbles after pricing public offering By Investing.com - Investing.com Canada
Sana Biotechnology stock tumbles after pricing public offering - Investing.com
Why Is Sana Biotechnology Stock Down 25% Today? - TipRanks
SANA Stocks Defy Expectations in Market - timothysykes.com
Sana Biotechnology shares fall 24.71% premarket after announcing a public offering of $75.0 million of shares. - AInvest
Sana Biotechnology slides after $75 mln equity offering - TradingView
Sana Biotechnology Raises $75 Million Through Share Offering - AInvest
Sana Biotechnology Prices $75 Million Share Offering - MarketScreener
Sana Biotechnology shares fall 16% premarket after announcing a public offering of $75.0 million of shares. - AInvest
Sana Biotechnology prices $75 million public offering at $3.35 per share - Investing.com Nigeria
Sana Biotechnology prices $75 million public offering at $3.35 per share By Investing.com - Investing.com South Africa
Sana Biotechnology announces pricing of public offering at $3.35 per share - MarketScreener
Sana Biotechnology Announces $75M Public Offering of Common Stock and Pre-Funded Warrants - AInvest
Sana Biotechnology Announces Pricing of Public Offering - Benzinga
Sana Biotechnology after launching $75 mln stock deal - TradingView
Sana Biotechnology launches $75 million public offering - Investing.com
Sana Biotechnology launches $75 million public offering By Investing.com - Investing.com Nigeria
Sana Biotechnology shares fall 14.12% after-hours following Seres Therapeutics' board changes and clinical advancement updates. - AInvest
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire
Sana Biotechnology shares rise 1.42% after-hours following positive study results on HIP-modified pancreatic islet cells. - AInvest
Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes - GlobeNewswire
Revolutionary Type 1 Diabetes Breakthrough: Patient Produces Insulin After 35 Years Through Novel Cell Transplant - Stock Titan
Sana Biotechnology Inc expected to post a loss of 21 cents a shareEarnings Preview - TradingView
What analysts say about Sana Biotechnology Inc. stockHigh-yield capital appreciation - Jammu Links News
What catalysts could drive Sana Biotechnology Inc. stock higher in 2025Achieve fast wealth growth with smart picks - Jammu Links News
When is Sana Biotechnology Inc. stock expected to show significant growthGet exclusive market insights for better trading - Jammu Links News
Is it the right time to buy Sana Biotechnology Inc. stockAmplify your gains with low-risk picks - Jammu Links News
Finanzdaten der Sana Biotechnology Inc-Aktie (SANA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):